Application 089454
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PROTAMINE SULFATE | PROTAMINE SULFATE | INJECTABLE;INJECTION | 10MG/ML | No | Yes |
| 002 | PROTAMINE SULFATE | PROTAMINE SULFATE | SOLUTION;INTRAVENOUS | 250MG/25ML (10MG/ML) | No | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1414 | PROTAMINE SULFATE | PROTAMINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1414 | PROTAMINE SULFATE | PROTAMINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 63323-229 | Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-229 | Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-229 | Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-229 | Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-229 | Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | ANDA | Current |